A cluster of methicillin-resistant Staphylococcus aureus infections has prompted Massachusetts Public Health Department officials to cite Bostons Beth Israel Deaconess Medical Center for serious deficiencies in infection-control practices, according to a news release. The 585-bed hospital has been ordered to initiate a plan of correction for the deficiency and undergo a full survey by the CMS in order to continue as a Medicare and Medicaid provider.
The citation follows a health department inspection of the facility in March after notification by Beth Israel officials that 19 newborns and 18 mothers who had given birth at the facility experienced MRSA infections shortly after being discharged. The infections, according to a blog posting made by Beth Israel CEO Paul Levy, were mostly superficial skin infections and breast infections. But according to health department officials, two of the patients experienced serious complications as a result of the MRSA infections and a total of 10 patients had to be hospitalized for treatment of their infections. All of the patients recovered.
The source of the infections has not been identified, but health department officials said evidence suggests a common source of infection as the same MRSA bacteria strain was found in each of the patients.